-
Kenya's new poaching problem: smuggling Giant Harvester Ants
-
WHO kicks off annual assembly amid hantavirus, Ebola crises
-
S. Korean blockbuster 'Hope' underscores growing film ambition
-
Train driver charged after deadly Bangkok bus collision
-
Angry Chinese table tennis fans demand apology for flag gaffe
-
India's lifeline ferry across strategic archipelago
-
Encroaching world threatens India's last 'uncontacted' tribe
-
India's strategic $9 bn megaport plan for pristine island
-
In Tierra del Fuego, a hunt for the rodent carrier of hantavirus
-
Mitchell leads Cavs past top-seeded Detroit into NBA East finals
-
China's April consumption, factory output growth slowest in years
-
Asian stocks sink, oil rises on US-Iran deadlock
-
Cleveland Cavaliers eliminate top-seeded Detroit from NBA playoffs
-
Who could be the 2026 World Cup's breakout star?
-
Humble PGA champ Rai celebrates English, Indian, Kenyan heritage
-
Hantavirus-hit cruise ship nears end of voyage, to dock in Rotterdam
-
He said, she said, AI said: Wall Street sex scandal rivets and confounds
-
UN General Assembly to take up climate change 'obligations' resolution
-
Four takeaways from Musk vs OpenAI trial
-
Jury to decide fate of Musk's blockbuster suit against OpenAI
-
Frustrated McIlroy drops F-bomb in exchange with PGA heckler
-
Defending champion Palou storms to Indy 500 pole
-
Messi shines as Inter Miami finally win at new stadium
-
Shai Gilgeous-Alexander wins second straight NBA MVP award
-
White House mass prayer event seeks to reclaim US Christian roots
-
International dive group joins Maldives search for missing Italians
-
'Staggering' Iran toll drives up global executions: Amnesty
-
Agronomics Limited Announces Net Asset Value Calculation as at 31 March 2026
-
Santa Barbara Schools Sexual Assault Complaint by Veen Firm
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 18
-
Rai wins first major at PGA with back-nine birdie blitz
-
Woad bags second LPGA title at Queen City Championship
-
Lebanon says Israeli strikes kill 7 as Hezbollah condemns talks
-
Revived La Rochelle trounce Top 14 leaders Toulouse
-
PSG beaten by Paris FC in Ligue 1 as Lille qualify for Champions League
-
Griezmann apologetic on emotional Atletico Madrid farewell
-
Raging Neymar forced off by refereeing error as Santos lose
-
Sinner extends Masters tournament streak on home turf, eyes French Open
-
Canadian cruise passenger confirmed positive for hantavirus
-
England see off gutsy France to clinch another Women's Six Nations
-
Sevilla safe despite Real Madrid defeat, Mallorca on brink
-
UK police detail arrests after far-right rally and counter demo
-
Smalley tees off with PGA lead and stars in hot pursuit
-
Trump issues dire warning to Iran to accept peace deal
-
West Ham on brink of Premier League relegation, Man Utd seal third
-
Bulgaria's Eurovision winner flies home to rapturous welcome
-
Starc takes four to keep Delhi alive in IPL
-
Kyiv residents protest 'dangerous' civil code, call for LGBTQ rights
-
Modiba thunderbolt gives Sundowns victory in African final first leg
-
World champions England see off France to clinch another Women's Six Nations
US cracks down on 'tranq' drug linked to fatal overdoses
The United States announced Tuesday a crackdown on unlawful imports of xylazine, an animal tranquilizer known as the "zombie drug" and which is increasingly linked to overdose deaths.
Xylazine, which also goes by the street name "tranq," has recently been found in illicitly manufactured fentanyl, heroin, cocaine and other drugs, presenting a "growing public health concern," the Food and Drug Administration (FDA) said.
"This action aims to prevent the drug from entering the US market for illicit purposes, while maintaining availability for its legitimate uses in animals," it said in a statement.
According to the National Institute on Drug Abuse, the percentage of all drug overdose deaths involving xylazine increased from two percent to 26 percent in the northeast state of Pennsylvania from 2015 to 2020.
Xylazine is typically used by veterinarians to sedate large animals such as horses and deer but the drug is not approved for use in humans.
It can slow breathing, blood pressure and heart rate to critically low levels and cause skin ulcers and abscesses that can lead to amputation.
The FDA said imports of xylazine would be subject to heightened scrutiny and seized if they appear to be unlawful.
"The FDA remains concerned about the increasing prevalence of xylazine mixed with illicit drugs, and this action is one part of broader efforts the agency is undertaking to address this issue," FDA commissioner Robert Califf said.
Y.Nakamura--AMWN